𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Role of dynamic contrast enhanced MRI in monitoring early response of locally advanced breast cancer to neoadjuvant chemotherapy

✍ Scribed by Martin D. Pickles; Martin Lowry; David J. Manton; Peter Gibbs; Lindsay W. Turnbull

Publisher
Springer US
Year
2005
Tongue
English
Weight
338 KB
Volume
91
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Association between serial dynamic contr
Association between serial dynamic contrast-enhanced MRI and dynamic 18F-FDG PET measures in patients undergoing neoadjuvant chemotherapy for locally advanced breast cancer
✍ Savannah C. Partridge; Risa K. Vanantwerp; Robert K. Doot; Xiaoyu Chai; Brenda F πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 588 KB

## Abstract ## Purpose To investigate the relationship between changes in vascularity and metabolic activity measured by dynamic contrast‐enhanced magnetic resonance imaging (DCE‐MRI) and dynamic ^18^F‐FDG‐positron emission tomography (PET) in breast tumors undergoing neoadjuvant chemotherapy. ##

Monitoring the response of patients with
Monitoring the response of patients with locally advanced breast carcinoma to neoadjuvant chemotherapy using [technetium 99m]-sestamibi scintimammography
✍ David A. Mankoff; Lisa K. Dunnwald; Julie R. Gralow; Georgiana K. Ellis; Mariann πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 221 KB πŸ‘ 2 views

## BACKGROUND. Mammographic and physical examination assessments of the response of locally advanced breast carcinoma (LABC) to neoadjuvant therapy have been shown to be inaccurate. The authors studied the feasibility and accuracy of [technetium 99m]-sestamibi (MIBI) for monitoring the response of